Scholarlink

<p>Tumor-associated macrophages (TAMs) are among the most abundant immune components within the breast cancer (BRCA) microenvironment and exert multifaceted roles in tumor progression, immune evasion, and therapy resistance. While traditionally classified along the M1/M2 polarization axis, emerging evidence from single-cell and spatial transcriptomic studies has revealed a spectrum of phenotypically diverse, functionally distinct TAM subsets. These subsets are shaped by BRCA molecular subtype, tumor stage, and microenvironmental factors such as cytokines, hypoxia, and metabolic cues, challenging the conventional dichotomy. </p><p>This review summarizes current understanding of TAM origin, polarization, and subtypes-specific functions across different breast cancers subtypes. Functionally, heterogeneous spatial-metabolic TAMs contribute to angiogenesis, metastasis, and immunosuppression—particularly their crosstalk with T cells and immune checkpoints. Emerging therapeutic strategies are discussed, including TAMs depletion and reprogramming. Altogether, to examine major challenges in TAM research, such as the lack of standardized classification systems and actionable biomarkers, proposes future directions for integrating TAM-targeted therapies into personalized immuno-oncology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The puppet master in the breast cancer “microecological community”: spatial and metabolic regulation of macrophage heterogeneity

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月6日

查看全文
  • Hao Wu,
  • Hong-Da Tian,
  • Liuying Zhao,
  • Dandan Liu,
  • Baohang Lin,
  • Xiaohong Wu

摘要

Tumor-associated macrophages (TAMs) are among the most abundant immune components within the breast cancer (BRCA) microenvironment and exert multifaceted roles in tumor progression, immune evasion, and therapy resistance. While traditionally classified along the M1/M2 polarization axis, emerging evidence from single-cell and spatial transcriptomic studies has revealed a spectrum of phenotypically diverse, functionally distinct TAM subsets. These subsets are shaped by BRCA molecular subtype, tumor stage, and microenvironmental factors such as cytokines, hypoxia, and metabolic cues, challenging the conventional dichotomy.

This review summarizes current understanding of TAM origin, polarization, and subtypes-specific functions across different breast cancers subtypes. Functionally, heterogeneous spatial-metabolic TAMs contribute to angiogenesis, metastasis, and immunosuppression—particularly their crosstalk with T cells and immune checkpoints. Emerging therapeutic strategies are discussed, including TAMs depletion and reprogramming. Altogether, to examine major challenges in TAM research, such as the lack of standardized classification systems and actionable biomarkers, proposes future directions for integrating TAM-targeted therapies into personalized immuno-oncology.